Not to be confused with acetylmethadol[1]
|  | |
| _and_(S%252CS)-Alphacetylmethadol_isomers_ball.png.webp) | |
| Clinical data | |
|---|---|
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H31NO2 | 
| Molar mass | 353.506 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Alphacetylmethadol (INN), or α-acetylmethadol (AAM), is a synthetic opioid analgesic.[3] Its levorotary enantiomer, levacetylmethadol, is an FDA-approved treatment for opioid addiction; however as of 2003 it is no longer used in the United States for this purpose.[3] Alphacetylmethadol is very similar in structure to methadone, a widely prescribed treatment for opioid addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act (presumably because it was never marketed in the US, as is the case with other common opiate/opioid medications such as heroin and prodine),[4] with an ACSCN of 9603 and a 2013 annual manufacturing quota of 2 grammes.
See also
References
- ↑ Richard Lawrence Miller (30 December 2002). The Encyclopedia of Addictive Drugs. Greenwood Publishing Group. p. 222. ISBN 978-0-313-31807-8. Retrieved 15 May 2012.
- ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- 1 2 Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology. 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424. S2CID 19815273.
- ↑ 21 U.S.C. § 812(b)(1)
| 
 
 | |||||||||||||||||||||||||
| μ-opioid (MOR) | 
 | ||||
|---|---|---|---|---|---|
| δ-opioid (DOR) | 
 | ||||
| κ-opioid (KOR) | 
 | ||||
| Nociceptin (NOP) | 
 | ||||
| Others | 
 
 
 | ||||
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.